About Us
Portfolio
How it works
- Invest
- Fundraise
- Advise
Insights
- Podcast
- Events
- Blog
- Newsletter
Sign In
Join

About Us
Portfolio
How it works
Insights
Sign In
Join

Browse articles by categories

Angel Investing Tips

Deep Technology

Startup Tips

User Tips

Industry Trends

Aerospace / Transportation

Energy / Green Technologies

Food & Agriculture

IT & Communications

Life Sciences

Deal Profile

Search for:

bone regeneration

A Tricky Bone to Pick: Avitus Deal Profile

Haley Sheetz | July 20th, 2016

Deal Profile Deep Technology Life Sciences Startup Tips

Time to read: 4 minutes

term sheets

Fundraising 101: Terms Sheets

admin | July 15th, 2016

Angel Investing Tips Fundraising 101 Startup Tips User Tips

Time to read: 3 minutes

Evaluating a Startup

Evaluating a Startup: 6 Questions To Ask Management Teams

admin | July 12th, 2016

Angel Investing Tips Startup Tips User Tips

Time to read: 3 minutes

Portfolio Diversification

Changing How You Look at Industry Sectors and Technologies Could Increase Your Portfolio Diversification (and Mitigate Risk)

Swati Chaturvedi | July 7th, 2016

Angel Investing Tips Deep Technology Industry Trends User Tips

Time to read: 3 minutes

tracking regeneration

Tracking Regeneration: Bell Biosystems Company Profile

admin | June 16th, 2016

Deal Profile Deep Technology Life Sciences Startup Tips

Time to read: 6 minutes

Saul Griffith - energy technology

A Hundred Ideas Coming Together: Saul Griffith’s Otherlab

Asma Stewart | May 5th, 2016

Aerospace / Transportation Energy / Green Technologies Food & Agriculture IT & Communications Life Sciences

Time to read: 7 minutes

insulin alternative

Resetting the Insulin Clock: Sensulin Deal Profile

Haley Sheetz | May 3rd, 2016

Deal Profile Startup Tips

Time to read: 6 minutes

Science and Technology Investing

Unfollow the Leader: Angel Investors Follow Their Own Investing Path

Swati Chaturvedi | April 24th, 2016

Angel Investing Tips User Tips

Time to read: 2 minutes

startup evaluation

Product Spotlight: Asking a Question

Shirley Li | April 22nd, 2016

Angel Investing Tips User Tips

Time to read: 3 minutes

5
...
7
8
9
10
11

Popular posts

Guest Post: Cancer Immunotherapy – Defense Against Enemies Foreign and Domestic

Deep Technology
How To Become an Angel Investor

Angel Investing Tips Angel Keyterms User Tips
Deep Tech Innovations in Diagnostics and Medical Technology Are Starting to Transform Healthcare

Deep Technology Industry Trends IT & Communications Life Sciences

ABOUT US
How it works
- Invest
- Fundraise
- Advise
- FAQs
JOIN
Learn
- Podcast
- Events
- Blog
LEGAL

© 2021 PROPEL(X) - All Rights Reserved.

This site is operated by Propel(x) Inc. (“Propel(x)”), which is not a registered broker dealer. Propel(x) does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities posted here are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. Propel(x) has not taken steps to verify the adequacy, accuracy, or completeness of the information. Neither Propel(x) nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind related to the adequacy, accuracy or completeness of any information on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.

Certain offerings posted on the platform and so designated are offered by Hubble Investments, Member FINRA / SIPC and an affiliate of Propel(x), located at EvoNexus Silicon Valley FinTech Incubator, 950 Park Place, Building 950/1, San Mateo CA 94403. Hubble Investments does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform. This website is intended solely for qualified investors. Private investments are highly illiquid and risky and are not suitable for all investors. Investments in early-stage private companies should only be part of your overall investment portfolio. Furthermore, the allocation to this asset sub-class may be best fulfilled through a balanced portfolio of different start-ups. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.

Become an Insider

Join a community of 10,000+ subscribers to receive our free newsletter covering trends and insights on startups, investors, events, blogs, and podcasts for technologies that matter.

Name*
Email*
Comments
This field is for validation purposes and should be left unchanged.

Thanks for Signing Up!

You're signed up for the Propel(x) newsletter. Be on the lookout for an email confirming your opt in preference. In the meantime, invite your friends to join the tribe too!